Literature DB >> 17659749

Onset to first visit intervals in childhood rheumatic diseases.

Cal Shapiro1, Lynn Maenz, Alomgir Hossain, Punam Pahwa, Alan Rosenberg.   

Abstract

OBJECTIVE: To determine time intervals between onset of symptoms of a childhood rheumatic disease and first visit to a pediatric rheumatology clinic and to evaluate factors influencing onset to first visit intervals.
METHODS: Onset to first visit intervals were analyzed in 836 children representing the 10 most common diseases in a pediatric rheumatology clinic population of 1093.
RESULTS: Among 836 subjects, 469 (56.1%) could identify month of symptom onset. Among patients with juvenile rheumatoid arthritis (JRA) 125 of 195 (64.1%) with pauciarticular, 58 of 105 (55.2%) with polyarticular, and 28 of 36 (77.8%) with systemic subtypes were able to determine time interval between symptom onset and first visit. Month intervals were confidently established in 80 of 250 with a spondyloarthropathy (32.4%), 19 of 52 (36.5%) with psoriatic arthropathy, 65 of 72 (90.3%) with Henoch-Schönlein purpura (HSP), 50 of 56 (89.3%) with Kawasaki disease, 22 of 34 (64.7%) with systemic lupus erythematosus, 13 of 18 (72.2%) with dermatomyositis, and 9 of 18 (50%) with localized scleroderma. Determination of onset was significantly more likely in HSP than in other diagnostic categories except systemic JRA, and more likely in Kawasaki disease than other disease categories except systemic JRA and dermatomyositis. In the group of 469, 287 (61.2%) were seen within 2 months of symptom onset and 447 (95.3%) within 1 year of symptom onset.
CONCLUSION: Diseases ordinarily typified by an abrupt and acute onset of symptoms were referred most promptly, suggesting that acuity of symptoms at disease onset is the factor that most influences promptness of referral. Prospective studies are required to establish how onset to first visit intervals might influence disease outcomes and to devise best practice referral guidelines.

Entities:  

Mesh:

Year:  2007        PMID: 17659749

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  3 in total

1.  Efficacy of early dental and ENT therapy in preventing nephropathy in pediatric Henoch-Schönlein purpura.

Authors:  Chiyoko N Inoue; Takako Nagasaka; Sachiko Matsutani; Masako Ishidoya; Rikako Homma; Yasushi Chiba
Journal:  Clin Rheumatol       Date:  2008-07-24       Impact factor: 2.980

2.  Testing population-based performance measures identifies gaps in juvenile idiopathic arthritis (JIA) care.

Authors:  Claire E H Barber; Lisa M Lix; Diane Lacaille; Deborah A Marshall; Kristine Kroeker; Susanne Benseler; Marinka Twilt; Heinrike Schmeling; Cheryl Barnabe; Glen S Hazlewood; Vivian Bykerk; Joanne Homik; J Carter Thorne; Jennifer Burt; Dianne Mosher; Steven Katz; Natalie J Shiff
Journal:  BMC Health Serv Res       Date:  2019-08-14       Impact factor: 2.655

3.  Access to pediatric rheumatology care for Juvenile Idiopathic Arthritis in the United Arab Emirates.

Authors:  Khulood Khawaja; Mustafa Al-Maini
Journal:  Pediatr Rheumatol Online J       Date:  2017-05-16       Impact factor: 3.054

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.